First-phase insulin secretion is positively correlated with alanine aminotransferase in young adults. 2021

Chung-Ze Wu, and Chang-Hsun Hsieh, and Chieh-Hua Lu, and Dee Pei, and Jin-Shuen Chen, and Yen-Lin Chen
Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taiwan.

BACKGROUND Type 2 diabetes (T2D) is known to be one of the most prevalent diseases, and its prevalence is significantly associated with age and metabolic syndrome (MetS). Few studies have been conducted on liver function, MetS and insulin secretion among young adults. OBJECTIVE In the present study, we explored the relationship between the liver function enzyme - alanine aminotransferase (ALT) - and first-phase insulin secretion (FPIS) among young adults. METHODS There were 22,971 men and 28,740 women, aged 18-27 years, assigned to subgroups according to the presence of MetS and quartiles of ALT values. Simple correlation was applied to evaluate their relationship. The difference between the slopes of these relationships and FPIS were statistically analyzed with Chris's calculator. RESULTS Most values for metabolic parameters, including ALT and FPIS, were determined to be relatively high in individuals with MetS. By contrast, individuals with MetS had lower high-density-lipoprotein cholesterol (HDL-C) counts and FPIS. Similar results were observed in the quartiles of ALT. Significant positive results were also found in the linear model. Depending on the ALT level, the slope change of FPIS still demonstrated a positive correlation between ALT and FPIS. This correlation was stronger for men than for women. CONCLUSIONS A positive correlation between ALT and FPIS exists among young adults. Moreover, this correlation was stronger for men than for women. Both the cause and the effect require further investigation.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults

Related Publications

Chung-Ze Wu, and Chang-Hsun Hsieh, and Chieh-Hua Lu, and Dee Pei, and Jin-Shuen Chen, and Yen-Lin Chen
April 2017, European journal of gastroenterology & hepatology,
Chung-Ze Wu, and Chang-Hsun Hsieh, and Chieh-Hua Lu, and Dee Pei, and Jin-Shuen Chen, and Yen-Lin Chen
May 2012, Scandinavian journal of clinical and laboratory investigation,
Chung-Ze Wu, and Chang-Hsun Hsieh, and Chieh-Hua Lu, and Dee Pei, and Jin-Shuen Chen, and Yen-Lin Chen
September 2022, The Journal of international medical research,
Chung-Ze Wu, and Chang-Hsun Hsieh, and Chieh-Hua Lu, and Dee Pei, and Jin-Shuen Chen, and Yen-Lin Chen
January 2021, Frontiers in endocrinology,
Chung-Ze Wu, and Chang-Hsun Hsieh, and Chieh-Hua Lu, and Dee Pei, and Jin-Shuen Chen, and Yen-Lin Chen
October 2012, Cardiovascular diabetology,
Chung-Ze Wu, and Chang-Hsun Hsieh, and Chieh-Hua Lu, and Dee Pei, and Jin-Shuen Chen, and Yen-Lin Chen
January 1993, Annales d'endocrinologie,
Chung-Ze Wu, and Chang-Hsun Hsieh, and Chieh-Hua Lu, and Dee Pei, and Jin-Shuen Chen, and Yen-Lin Chen
January 2011, Circulation journal : official journal of the Japanese Circulation Society,
Chung-Ze Wu, and Chang-Hsun Hsieh, and Chieh-Hua Lu, and Dee Pei, and Jin-Shuen Chen, and Yen-Lin Chen
January 2011, Circulation journal : official journal of the Japanese Circulation Society,
Chung-Ze Wu, and Chang-Hsun Hsieh, and Chieh-Hua Lu, and Dee Pei, and Jin-Shuen Chen, and Yen-Lin Chen
March 2022, European journal of gastroenterology & hepatology,
Chung-Ze Wu, and Chang-Hsun Hsieh, and Chieh-Hua Lu, and Dee Pei, and Jin-Shuen Chen, and Yen-Lin Chen
January 2018, Mediators of inflammation,
Copied contents to your clipboard!